VIR Annual Total Liabilities
$328.82 M
-$395.30 M-54.59%
31 December 2023
Summary:
As of January 23, 2025, VIR annual total liabilities is $328.82 million, with the most recent change of -$395.30 million (-54.59%) on December 31, 2023. During the last 3 years, it has risen by +$126.92 million (+62.86%). VIR annual total liabilities is now -54.59% below its all-time high of $724.13 million, reached on December 31, 2022.VIR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIR Quarterly Total Liabilities
$257.63 M
+$21.74 M+9.22%
30 September 2024
Summary:
As of January 23, 2025, VIR quarterly total liabilities is $257.63 million, with the most recent change of +$21.74 million (+9.22%) on September 30, 2024. Over the past year, it has increased by +$21.74 million (+9.22%). VIR quarterly total liabilities is now -70.93% below its all-time high of $886.12 million, reached on March 31, 2022.VIR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIR Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.6% | +9.2% |
| 3 y3 years | +62.9% | -62.9% |
| 5 y5 years | -11.3% | -62.9% |
VIR Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.6% | at low | -70.9% | +9.2% |
| 5 y | 5-year | -54.6% | +273.1% | -70.9% | +192.3% |
| alltime | all time | -54.6% | +273.1% | -70.9% | +365.1% |
Vir Biotechnology Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $257.63 M(+9.2%) |
| June 2024 | - | $235.88 M(-4.4%) |
| Mar 2024 | - | $246.61 M(-25.0%) |
| Dec 2023 | $328.82 M(-54.6%) | $328.82 M(-11.1%) |
| Sept 2023 | - | $369.81 M(-14.7%) |
| June 2023 | - | $433.67 M(-37.6%) |
| Mar 2023 | - | $695.13 M(-4.0%) |
| Dec 2022 | $724.13 M(+38.6%) | $724.13 M(+32.6%) |
| Sept 2022 | - | $546.12 M(-18.1%) |
| June 2022 | - | $666.98 M(-24.7%) |
| Mar 2022 | - | $886.12 M(+69.6%) |
| Dec 2021 | $522.42 M | $522.42 M(+56.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $333.94 M(+4.3%) |
| June 2021 | - | $320.26 M(-33.9%) |
| Mar 2021 | - | $484.63 M(+140.0%) |
| Dec 2020 | $201.91 M(+129.1%) | $201.91 M(+54.2%) |
| Sept 2020 | - | $130.90 M(+20.7%) |
| June 2020 | - | $108.46 M(+12.1%) |
| Mar 2020 | - | $96.78 M(+9.8%) |
| Dec 2019 | $88.13 M(-76.2%) | $88.13 M(-87.5%) |
| Sept 2019 | - | $703.44 M(+1169.8%) |
| June 2019 | - | $55.40 M(-85.1%) |
| Dec 2018 | $370.77 M(+15.7%) | $370.77 M |
| Dec 2017 | $320.48 M | - |
FAQ
- What is Vir Biotechnology annual total liabilities?
- What is the all time high annual total liabilities for Vir Biotechnology?
- What is Vir Biotechnology annual total liabilities year-on-year change?
- What is Vir Biotechnology quarterly total liabilities?
- What is the all time high quarterly total liabilities for Vir Biotechnology?
- What is Vir Biotechnology quarterly total liabilities year-on-year change?
What is Vir Biotechnology annual total liabilities?
The current annual total liabilities of VIR is $328.82 M
What is the all time high annual total liabilities for Vir Biotechnology?
Vir Biotechnology all-time high annual total liabilities is $724.13 M
What is Vir Biotechnology annual total liabilities year-on-year change?
Over the past year, VIR annual total liabilities has changed by -$395.30 M (-54.59%)
What is Vir Biotechnology quarterly total liabilities?
The current quarterly total liabilities of VIR is $257.63 M
What is the all time high quarterly total liabilities for Vir Biotechnology?
Vir Biotechnology all-time high quarterly total liabilities is $886.12 M
What is Vir Biotechnology quarterly total liabilities year-on-year change?
Over the past year, VIR quarterly total liabilities has changed by +$21.74 M (+9.22%)